BLLN
BillionToOne, Inc. Class A Common StockNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$4.58B
P/E Ratio
184.54
EPS
$0.54
Beta
—
52W High
$138.70
52W Low
$61.96
50-Day MA
$87.36
200-Day MA
$88.68
Dividend Yield
—
Profit Margin
7.02%
Forward P/E
—
PEG Ratio
—
About BillionToOne, Inc. Class A Common Stock
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company is headquartered in Menlo Park, California.
Fundamentals
| Revenue (TTM) | $354.54M |
| Gross Profit (TTM) | $249.58M |
| EBITDA | $43.03M |
| Operating Margin | 16.50% |
| Return on Equity | 8.73% |
| Return on Assets | 4.46% |
| Revenue/Share (TTM) | $14.31 |
| Book Value | $11.00 |
| Price-to-Book | 9.06 |
| Price-to-Sales (TTM) | 12.93 |
| EV/Revenue | 11.82 |
| EV/EBITDA | 99.51 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 83.80% |
| Shares Outstanding | $41.44M |
| Float | $27.54M |
| % Insiders | 46.83% |
| % Institutions | 38.32% |
Historical Volatility
HV 10-Day
87.76%
HV 20-Day
78.65%
HV 30-Day
98.82%
HV 60-Day
90.54%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($117.71 target)
2
Strong Buy4
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026